Online Medical Course on Chronic Fatigue Syndrome (ME/CFS) Diagnosis and Treatment - Just Released   Not Yet Rated ProHealth.com • October 12, 2008 Tweet previous article next article For healthcare professionals who want to stay up-to-date on chronic fatigue syndrome (ME/CFS) best practices: Medscape – a resource site for healthcare professionals – announced the release on October 9 of a new online educational course titled “Chronic Fatigue Syndrome: From Diagnosis to Management.” Physicians, nurses, and pharmacists who study the free accredited course content and pass the post-test will earn continuing education credits. Content Providers - Leading Clinicians and Advocates The authors of the course are Lucinda Bateman, MD, Charles Lapp, MD, and Kim McCleary and Marcia Harmon (CEO and Communications Director of the CFIDS Association, respectively). Funding was provided by an independent educational grant from the CFIDS association, and Medscape. Learning Objectives The course is designed to enable a healthcare team to: 1. Identify the 8 case-defining symptoms and other common symptoms that may indicate a CFS diagnosis 2. Demonstrate clinical decision-making strategies to make a diagnosis of CFS 3. Recognize barriers to diagnosis and to effective therapeutic management of CFS 4. Summarize the components of supportive care for CFS patients 5. Identify basic clinical approaches to symptomatic treatment, including pharmacologic and nonpharmacologic interventions 6. Explain the importance of pacing activity in the treatment of CFS and identify specific treatment guidelines for activity management.

previous article   Not Yet Rated next article Tweet

RELATED PRODUCT CATEGORIES

ProHealth offers a wide range of nutritional supplements for optimal health.* *These products are not intended to diagnose, treat, cure, or prevent any disease. Brain Supplements Cuddle Ewe Energy Supplements Goodnighties Immune Support ME/CFS Support Relaxation Sleep Help Stress Management

DISCUSS THIS ARTICLE   (0 existing comments)
[ Be the first to comment on this article ]